NCT03589768: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03589768 |
|---|---|
| Title | A Phase II Double-Blind Trial to Evaluate the Safety, Immunogenicity and Effect on Infant Immune Responses of a Single Dose of Tdap in Pregnant Women in Mali |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 24, 2019 |
| Completion date | July 1, 2020 |
| Required reporting date | July 1, 2023, midnight |
| Actual reporting date | Nov. 17, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |